GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosenic (XBRU:BIOS) » Definitions » 1-Year Share Buyback Ratio

Biosenic (XBRU:BIOS) 1-Year Share Buyback Ratio : -97.70% (As of Jun. 2024 )


View and export this data going back to 2015. Start your Free Trial

What is Biosenic 1-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Biosenic's current 1-Year Share Buyback Ratio was -97.70%.

XBRU:BIOS's 1-Year Share Buyback Ratio is ranked worse than
86.45% of 1173 companies
in the Biotechnology industry
Industry Median: -11.2 vs XBRU:BIOS: -97.70

Competitive Comparison of Biosenic's 1-Year Share Buyback Ratio

For the Biotechnology subindustry, Biosenic's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biosenic's 1-Year Share Buyback Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biosenic's 1-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Biosenic's 1-Year Share Buyback Ratio falls into.


;
;

Biosenic 1-Year Share Buyback Ratio Calculation

Biosenic's 1-Year Share Buyback Ratio for the quarter that ended in Jun. 2024 is calculated as

1-Year Share Buyback Ratio=(Shares Outstanding (EOP) (Jun. 2023 ) - Shares Outstanding (EOP) (Jun. 2024 )) / Shares Outstanding (EOP) (Jun. 2023 )
=(127.134 - 251.313) / 127.134
=-97.7%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biosenic  (XBRU:BIOS) 1-Year Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Biosenic 1-Year Share Buyback Ratio Related Terms

Biosenic Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosenic (XBRU:BIOS) » Definitions » 1-Year Share Buyback Ratio
Comparable Companies
XBRU:OXUR VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:UCB XBRU:ARGX ONC XKRX:068270 BNTX INSM HKSE:01801 SMMT RPRX XKRX:196170 INCY HKSE:02269 OCSE:GMAB HKSE:01177
Traded in Other Exchanges
0R55:UK BT1:Germany
Address
Rue Granbonpre 11, Batiment H (bte 24), Mont-St-Guibert, BEL, 1435
Website
https://www.biosenic.com
Biosenic is engaged in the development of cell therapy products for orthopaedics and bone diseases. The product pipeline of the company includes; ALLOB for treatment of delayed-union fractures, spinal fusion procedures and revision spinal fusion, and PREOB. In addition, the firm is also focused on conducting preclinical research on next-generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications.